Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 07 - 27 tags : Therapy save search
AC Immune acquires AFFiRiS’ Specific Active Immunotherapy (SAIT) anti-alpha-synuclein programs targeting neurodegenerative diseases
Published: 2021-07-27 (Crawled : 22:00) - biospace.com/
ACIU | $2.42 10K
|
Health Technology
|
| O: 1.83%
H: 2.76%
C: -1.24%
disease neurodegenerative immunotherapy therapy alpha-synuclein
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages ATI Physical Therapy (ATIP) Investors to Contact Firm's Attorneys Now, Firm Investigating Possible Asset Impairments and Securities Law Violations
Published: 2021-07-27 (Crawled : 20:00) - prnewswire.com
ATIP 4 | $4.17 19
|
Manufacturing
|
| O: 2.36%
H: 2.94%
C: -1.53%
therapy trial
Recover Losses: Ademi LLP Investigates Claims of Securities Fraud against ATI Physical Therapy, Inc.
Published: 2021-07-27 (Crawled : 09:00) - prnewswire.com
ATIP 4 | $4.17 19
|
Manufacturing
|
| O: -3.39%
H: 0.0%
C: -16.23%
therapy
Gainers vs Losers
| 77% | 23% |
Top 10 Gainers
TIRX | $1.13 133.09% 44M
|
AGBA | $0.8978 124.45% 60M
|
Finance
BPTH | $6.18 90.74% 39M
|
Health Technology
INVO | $1.44 89.47% 3M
|
Health Technology
SINT | $0.0588 57.64% 240M
|
Health Technology
XPON | $2.66 37.82% 5.2M
|
THCH | $1.38 32.69% 9.9M
|
n/a
ALRN | $5.605 31.88% 210K
|
Health Technology
HOLO | $2.92 30.36% 22M
|
VTNR S | $1.25 27.66% 3.2M
|
Industrial Services
Your saved searches
Save your searches and get alerts when important news are released.